Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid.

Airway wall remodeling is an established pathological feature in asthma. Its causes are not well understood, but one mediator of potential relevance is transforming growth factor-beta 1 (TGF-beta 1). We have measured levels of immunoreactive TGF-beta 1 in bronchoalveolar lavage (BAL) fluid from clinically stable atopic asthmatics and healthy control subjects. We have also examined the influence of allergen exposure on TGF-beta 1 release in the airways using a segmental bronchoprovocation model, with BAL performed at two time points following endobronchial allergen and sham saline challenges. Basal concentrations of TGF-beta 1 were significantly higher in asthmatics than control subjects (median 8.0 versus 5.5 pg/ml, p = 0.027). Following segmental bronchoprovocation, concentrations of TGF-beta 1 at the allergen- and saline-challenged sites were not significantly different after 10 min, (31.3 versus 25.0 pg/ml, p = 0.78), but after 24 h there were significantly higher TGF-beta 1 concentrations at the allergen-challenged sites (46.0 versus 21.5 pg/ml, p = 0.017). We conclude that basal TGF-beta 1 levels in the airways are elevated in atopic asthma and that these levels increase further in response to allergen exposure. These findings are consistent with the hypothesis that TGF-beta 1 is implicated in airway wall remodeling in asthma.

[1]  P. Howarth,et al.  Airway wall remodelling in asthma. , 1997, Thorax.

[2]  R. Baumgartner,et al.  Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. , 1996, Journal of immunology.

[3]  M. Jordana,et al.  Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. , 1996, American journal of respiratory cell and molecular biology.

[4]  P. Howarth,et al.  Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release. , 1996, American journal of respiratory and critical care medicine.

[5]  P. Howarth,et al.  Safety aspects of local endobronchial allergen challenge in asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[6]  P. Howarth,et al.  Role of Mast Cells and Basophils in Asthma (Part 1 of 2) , 1995 .

[7]  S. Galli,et al.  Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[8]  J. Hogg,et al.  Transforming growth factor beta 1 gene expression in human airways. , 1994, Thorax.

[9]  P. Howarth,et al.  Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. , 1993, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[10]  W. Gold,et al.  Dog mastocytoma cells produce transforming growth factor beta 1. , 1992, The Journal of clinical investigation.

[11]  P. Paré,et al.  A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[12]  C. Harley,et al.  Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). , 1992, The Journal of clinical investigation.

[13]  P. Howarth,et al.  The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. , 1991, The American review of respiratory disease.

[14]  D. Rifkin,et al.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Moses,et al.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension. , 1990, The Journal of clinical investigation.

[16]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[17]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[18]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[19]  R. Crystal,et al.  High levels of transforming growth factor-beta are present in the epithelial lining fluid of the normal human lower respiratory tract. , 1988, The American review of respiratory disease.

[20]  K. Miyazono,et al.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.